IL97821A0 - 3,5-disubstituted 2-isoxazolines and isoxazoles,processes for their preparation,agents containing them and their use - Google Patents
3,5-disubstituted 2-isoxazolines and isoxazoles,processes for their preparation,agents containing them and their useInfo
- Publication number
- IL97821A0 IL97821A0 IL97821A IL9782191A IL97821A0 IL 97821 A0 IL97821 A0 IL 97821A0 IL 97821 A IL97821 A IL 97821A IL 9782191 A IL9782191 A IL 9782191A IL 97821 A0 IL97821 A0 IL 97821A0
- Authority
- IL
- Israel
- Prior art keywords
- isoxazolines
- isoxazoles
- disubstituted
- processes
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/04—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
- C07F9/653—Five-membered rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Psychiatry (AREA)
- Biochemistry (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4011880 | 1990-04-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL97821A0 true IL97821A0 (en) | 1992-06-21 |
Family
ID=6404301
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL97821A IL97821A0 (en) | 1990-04-12 | 1991-04-10 | 3,5-disubstituted 2-isoxazolines and isoxazoles,processes for their preparation,agents containing them and their use |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5273989A (cs) |
| EP (1) | EP0451790A1 (cs) |
| JP (1) | JPH04234857A (cs) |
| KR (1) | KR910018363A (cs) |
| CN (1) | CN1055537A (cs) |
| AU (1) | AU7428591A (cs) |
| BR (1) | BR9101475A (cs) |
| CA (1) | CA2040219A1 (cs) |
| CS (1) | CS101391A2 (cs) |
| FI (1) | FI911718L (cs) |
| HU (1) | HU911183D0 (cs) |
| IE (1) | IE911235A1 (cs) |
| IL (1) | IL97821A0 (cs) |
| NO (1) | NO911432L (cs) |
| PT (1) | PT97329A (cs) |
| ZA (1) | ZA912701B (cs) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU6115794A (en) * | 1993-03-02 | 1994-09-26 | Fujisawa Pharmaceutical Co., Ltd. | Isoxazole derivative |
| CN1046274C (zh) * | 1993-11-26 | 1999-11-10 | 辉瑞大药厂 | 用作消炎剂的异噁唑啉化合物 |
| JP2818820B2 (ja) * | 1993-11-26 | 1998-10-30 | ファイザー・インク. | 抗炎症剤としての3−アリール−2−イソオキサゾリン類 |
| US5767118A (en) * | 1994-10-26 | 1998-06-16 | Merck & Co., Inc. | 4-Heterocyclic peperidines promote release of growth hormone |
| FR2752163B1 (fr) * | 1996-08-12 | 1998-10-30 | Pf Medicament | Utilisation de l'efaroxan pour la fabricaton de medicament destine au traitement de la maladie de huntington |
| KR19990011062A (ko) * | 1997-07-21 | 1999-02-18 | 손욱 | 이소옥사졸리딘 고리 함유 액정화합물 및 이를 포함하고 있는 액정 조성물 |
| US6319937B1 (en) * | 1998-11-18 | 2001-11-20 | Dupont Pharmaceuticals Company | Isoxazoline fibrinogen receptor antagonists |
| JP2003508512A (ja) | 1999-09-08 | 2003-03-04 | ギルフォード ファーマシュウティカルズ インコーポレイテッド | 非ペプチド性サイクロフィリン結合化合物とその用途 |
| US6656971B2 (en) | 2001-01-25 | 2003-12-02 | Guilford Pharmaceuticals Inc. | Trisubstituted carbocyclic cyclophilin binding compounds and their use |
| JP4471262B2 (ja) * | 2002-03-07 | 2010-06-02 | 株式会社エス・ディー・エス バイオテック | 置換イソキサゾールアルキルアミン誘導体及び農園芸用殺菌剤 |
| EP1658285B1 (en) * | 2003-08-20 | 2007-05-02 | Eli Lilly And Company | Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide |
| ATE350369T1 (de) | 2003-08-20 | 2007-01-15 | Lilly Co Eli | Verbindungen, verfahren und formulierungen zur oralen verabreichung einer glucagon like peptide (glp)-1-verbindung oder eines am melanocortin-4- rezeptor (mc4) als agonist wirkenden peptids |
| EP1819721A1 (en) * | 2004-11-19 | 2007-08-22 | Plant Bioscience Limited | Microcin b17 analogs and methods for their preparation and use |
| JP2010533644A (ja) * | 2007-05-31 | 2010-10-28 | 聡美 庭山 | ハーフエステルの合成方法 |
| US9149465B2 (en) * | 2009-05-18 | 2015-10-06 | Infinity Pharmaceuticals, Inc. | Isoxazolines as inhibitors of fatty acid amide hydrolase |
| US8927551B2 (en) * | 2009-05-18 | 2015-01-06 | Infinity Pharmaceuticals, Inc. | Isoxazolines as inhibitors of fatty acid amide hydrolase |
| US8765735B2 (en) * | 2009-05-18 | 2014-07-01 | Infinity Pharmaceuticals, Inc. | Isoxazolines as inhibitors of fatty acid amide hydrolase |
| JP6610905B2 (ja) * | 2015-02-27 | 2019-11-27 | オーピーバイオファクトリー株式会社 | カケロマイシンおよびその誘導体の製造方法 |
| AU2017359023B2 (en) | 2016-11-08 | 2021-12-09 | Bristol-Myers Squibb Company | 3-substituted propionic acids as alpha v integrin inhibitors |
| CN111333590B (zh) * | 2018-12-18 | 2022-05-17 | 沈阳中化农药化工研发有限公司 | 一种异恶唑烷盐酸盐的制备方法 |
| CN113149926B (zh) * | 2021-04-30 | 2023-05-26 | 华侨大学 | 一种3,5-二取代异恶唑衍生物的制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA826165A (en) * | 1969-10-28 | Gagneux Andre | Process for the production of an isoxazole derivative | |
| US3152139A (en) * | 1961-10-17 | 1964-10-06 | Geigy Chem Corp | Certain aminoisoxazolone derivatives |
| CH450423A (de) * | 1965-06-03 | 1968-01-31 | Geigy Ag J R | Verfahren zur Herstellung von 3-Hydroxy-5-aminomethyl-isoxazol |
| DK150615C (da) * | 1982-10-26 | 1987-11-09 | Cheminova As | Fremgangsmaade til fremstilling af substituerede 3-isoxazololer |
| CA1261335A (en) * | 1984-08-29 | 1989-09-26 | Hoffmann-La Roche Limited/Hoffmann-La Roche Limitee | Ethylenediamine monoamide derivatives |
| WO1988009330A1 (en) * | 1987-05-20 | 1988-12-01 | Zambon Group S.P.A. | Isoxazoles with nootropic activity |
| DE3736113A1 (de) * | 1987-10-26 | 1989-05-03 | Hoechst Ag | Arzneimittel, darin enthaltene phosphorhaltige 2-isoxazoline und isoxazole, sowie herstellungsverfahren fuer diese heterocyclischen verbindungen |
| DE3914969A1 (de) * | 1989-05-02 | 1990-11-08 | Schering Ag | 5-substituierte 3-arylisoxazol-derivate, deren herstellung und verwendung als schaedlingsbekaempfungsmittel |
| JP2786683B2 (ja) * | 1989-08-15 | 1998-08-13 | 三共株式会社 | グリコール誘導体およびその用途 |
-
1991
- 1991-04-09 EP EP91105614A patent/EP0451790A1/de not_active Withdrawn
- 1991-04-10 IL IL97821A patent/IL97821A0/xx unknown
- 1991-04-10 FI FI911718A patent/FI911718L/fi unknown
- 1991-04-10 CS CS911013A patent/CS101391A2/cs unknown
- 1991-04-10 KR KR1019910005696A patent/KR910018363A/ko not_active Withdrawn
- 1991-04-10 US US07/683,068 patent/US5273989A/en not_active Expired - Fee Related
- 1991-04-11 IE IE123591A patent/IE911235A1/en unknown
- 1991-04-11 HU HU911183A patent/HU911183D0/hu unknown
- 1991-04-11 NO NO91911432A patent/NO911432L/no unknown
- 1991-04-11 BR BR919101475A patent/BR9101475A/pt unknown
- 1991-04-11 PT PT97329A patent/PT97329A/pt not_active Application Discontinuation
- 1991-04-11 ZA ZA912701A patent/ZA912701B/xx unknown
- 1991-04-11 AU AU74285/91A patent/AU7428591A/en not_active Abandoned
- 1991-04-11 CA CA002040219A patent/CA2040219A1/en not_active Abandoned
- 1991-04-11 JP JP3105156A patent/JPH04234857A/ja active Pending
- 1991-04-11 CN CN91102287A patent/CN1055537A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| NO911432D0 (no) | 1991-04-11 |
| IE911235A1 (en) | 1991-10-23 |
| US5273989A (en) | 1993-12-28 |
| NO911432L (no) | 1991-10-14 |
| EP0451790A1 (de) | 1991-10-16 |
| KR910018363A (ko) | 1991-11-30 |
| FI911718A0 (fi) | 1991-04-10 |
| AU7428591A (en) | 1991-10-17 |
| BR9101475A (pt) | 1991-11-26 |
| CA2040219A1 (en) | 1991-10-13 |
| JPH04234857A (ja) | 1992-08-24 |
| CN1055537A (zh) | 1991-10-23 |
| FI911718A7 (fi) | 1991-10-13 |
| FI911718L (fi) | 1991-10-13 |
| PT97329A (pt) | 1992-01-31 |
| ZA912701B (en) | 1991-12-24 |
| CS101391A2 (en) | 1991-11-12 |
| HU911183D0 (en) | 1991-10-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL97821A0 (en) | 3,5-disubstituted 2-isoxazolines and isoxazoles,processes for their preparation,agents containing them and their use | |
| ZA909410B (en) | Isoxazolines,their preparation,and their use as plantprotecting agents | |
| ZA919059B (en) | Substituted azoles,process for their preparation,agents containing them and their use | |
| PH24746A (en) | 2,3-d/substituted isoxazolidines, agents containing them and their use | |
| IL86901A0 (en) | 6,7-dihydropyrazolo-(1,5-a)(1,3,5)triazine-2-sulphonamide derivatives and herbicidal compositions containing the same | |
| ZA916500B (en) | Plant-protecting agents containing isoxazolines or isothiazolines,and novel isoxazolines and isothiazolines | |
| IL94764A0 (en) | Endoparasiticidal agents containing 3-hydroxybenzothiophenes,certain new such compounds and their preparation | |
| GB2066812B (en) | 5'-acyl-uridine derivatives and processes for the preparation thereof | |
| IL85942A0 (en) | 1,5-substituted 1h-imidazoles,their preparation and their use as herbicides | |
| IL95050A0 (en) | 5-substituted 1,3,4-thiadiazole derivatives,and pesticidal compositions containing the same | |
| GB2240780B (en) | Substituted 1,3-diaminobenzenes,processes for their preparation and colouring agents containing them | |
| IL98309A0 (en) | Plant-protecting substituted isoxazolines,isoxazoles,isothiozolines and isothiazoles,processes for their preparation and their use | |
| IL86028A0 (en) | Novel pyrrolidine-2-(1,3-dicarbonyl)derivatives,their preparation,agents containing them,and their use | |
| ZA90975B (en) | 2,3,23-trihydroxy-urs-12-ene and its derivatives,processes for their preparation and their use | |
| ZA916433B (en) | Novel pyrrolobenzimidazoles,imidazobenzoxazinones and imidazoquinolones,process for their preparation and their use and preparations containing the compounds | |
| ZA891799B (en) | New 3,4,5-substituted 4h-1,2,4-triazoles,the preparation and use thereof | |
| ZA872720B (en) | Derivative of 1,5-diphenyl-1h-1,2,4-triazole-3-carboxamide and herbicidal composition containing the same | |
| IL111226A (en) | 1,3-oxazin-4-one derivatives process for their preparation and herbicides containing the same | |
| PH22967A (en) | Bis-tert.-butylamino-substituted 1,3,5-triazine derivatives, medidaments containing these compounds and their use | |
| IL94057A0 (en) | 5-substituted 3-arylisoxazole derivatives and insecticidal compositions containing the same | |
| IL100187A0 (en) | Process for the preparation of bromonitro-alcohols,dibromonitro-alcohols and mixtures thereof | |
| HU913818D0 (en) | New 2,6-alkoxy-phenyl-alkyl-ketones and herbicide preparatives containing said compounds | |
| OA09328A (en) | "Heterocyclic compounds". | |
| EP0284422A3 (en) | 4,5-dihydro-1h-1,2,4-triazole-3-carboxamide derivatives and herbicidal composition containing the same | |
| IL85449A (en) | 26,27-mono-and 14,15:26,27-diepoxide 23-deoxy-ll-f28249 derivatives and parasiticidal use |